Moderna's Covid-19 vaccine could be approved for emergency use within 24 to 72 hours after the US health regulator's advisory committee meeting, Chief Executive Officer Stéphane Bancel said.<br />''&nbsp;<br />''The Food and Drug Administration is scheduled to hold the meeting on December 17 to discuss the company's request for emergency use authorisation for its vaccine.<br />''&nbsp;<br />''Bancel said, Moderna currently has millions of doses of vaccines that can be shipped as soon as its request is granted.<br />''&nbsp;<br />''<span style="color: #222222;">Moderna, which is one of the front-runners in the race to develop a coronavirus vaccine, has applied for emergency authorisations both in the US and the EU after full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns.</span><br />
News On AIR | December 3, 2020 9:06 AM
Moderna CEO expects emergency use nod for COVID-19 vaccine after FDA panel meet